RJA
MRT

Raymond James & Associates’s MedEquities Realty Trust, Inc. MRT Stock Holding History

Raymond James & Associates’s Portfolio MRT Stock Details MRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-53,537
Closed -$366K – 3759
2018
Q4 		$366K Sell
53,537
-10,114
-16% -$79.3K ﹤0.01% 2744
2018
Q3 		$619K Buy
63,651
+33,553
+111% +$356K ﹤0.01% 2563
2018
Q2 		$332K Sell
30,098
-5,420
-15% -$55.9K ﹤0.01% 2954
2018
Q1 		$373K Buy
35,518
+10,251
+41% +$109K ﹤0.01% 2752
2017
Q4 		$283K Sell
25,267
-5,402
-18% -$61.2K ﹤0.01% 2876
2017
Q3 		$360K Sell
30,669
-6,685
-18% -$79.3K ﹤0.01% 2671
2017
Q2 		$471K Sell
37,354
-7,246
-16% -$86.7K ﹤0.01% 2457
2017
Q1 		$500K Sell
44,600
-15,100
-25% -$169K ﹤0.01% 2373
2016
Q4 		$663K Buy
59,700
+30,500
+104% +$341K ﹤0.01% 2162
2016
Q3 		$343K Buy
+29,200
New +$341K ﹤0.01% 2530

Other funds holding MRT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Chicago Capital Management Chicago, Illinois $112M AUM 76.54% 1-Year Est. Return
ACB
Aristotle Capital Boston Boston, Massachusetts $1.61B AUM 19.82% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
VI
Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Raymond James & Associates's MRT Position: Q1 2019 in Review

Raymond James & Associates sold out of MedEquities Realty Trust, Inc. (MRT) in Q1 2019, closing a stake of 53,537 shares — an estimated $366K sold.

Raymond James & Associates first reported a position in MRT in Q3 2016 and held it in 10 quarters. The position peaked at $663K in Q4 2016. 103 funds tracked by Wall St. Rank hold MRT as of Q1 2019.

  • Raymond James & Associates reported no remaining MedEquities Realty Trust, Inc. position as of Q1 2019 after selling out during the quarter.
  • Raymond James & Associates sold 53,537 MedEquities Realty Trust, Inc. shares in Q1 2019, an estimated $366K.
  • Raymond James & Associates first reported a position in MedEquities Realty Trust, Inc. in Q3 2016 and held it in 10 quarters.
  • Raymond James & Associates's MedEquities Realty Trust, Inc. position peaked at $663K in Q4 2016.
  • 103 funds tracked by Wall St. Rank held MedEquities Realty Trust, Inc. as of Q1 2019.

Based on Raymond James & Associates's 13F filing for Q1 2019, filed 6 May 2019.